BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Spectral Molecular Imaging, a wholly-owned subsidiary of Cascade Technologies, Inc. (OTCBB: CSDT), has announced the availability of a new Investor Information Brief outlining the Company’s proprietary technology and its strategy to develop a line of optical imaging devices for earlier detection of cancer and other major disease.
